02190.HK
Zylox-Tonbridge Medical Technology Co., Ltd.
HKSE · Healthcare · Medical - Devices · CN
HKD 20.64
+0.00%Year over year
Reported trailing growth
- Revenue
- +34.4%
- EBITDA
- +224.3%
- EBIT
- +573.1%
- EPS
- +103.3%
- Free cash flow
- +53.2%
- Operating cash flow
- -2.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +46.8%
- EBITDA
- +255.2%
- EBIT
- +222.8%
- Net income
- +143.7%
- EPS
- +145.2%
- Free cash flow
- +1656.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026